Royalty Pharma plc

RPRXNASDAQHealthcare● Active

$56.33

+$0.46(+0.82%)

Market Cap$24.2B

P/E Ratio—

52W High$56.07

52W Low$33.37

Avg Volume3.6M

Open$56.00

Beta0.42

Net Income Financials Revenue

Royalty Pharma plc (RPRX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

RPRX · net income · updated Jun 8, 2026

Core profitability metrics

RPRX · net income · margin · TTM · CAGR

Net income was $770.9M for FY2025 (fiscal year ending 2025-12-31), down 10.2% year-over-year. Net profit margin was 32.4%. Based on available data, Royalty Pharma plc has been profitable since at least 2015.

FY2025 Net Income$770.9M▼ -10.2% YoY

Trailing 12M (TTM)$827.6Mtrailing 4 quarters sum

Net Profit Margin32.4%$770.9M ÷ $2.38B

YoY Change-10.2%—

5-Year CAGR-4.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2015

▸ FMP /income-statement · Annual · RPRX net income history · RPRX profit margin

Annual net income data

RPRX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$770.9M▼ 10.2%32.4%$2.38B

FY2024$859.0M▼ 24.3%38.0%$2.26B

FY2023$1.13B▲ +2549.5%48.2%$2.35B

FY2022$42.8M▼ 93.1%1.9%$2.24B

FY2021$619.7M▼ 36.4%27.1%$2.29B

Net income vs peers (Healthcare)

RPRX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Royalty Pharma plcYOU

RPRX

$770.9M-10.2%32.4%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Royalty Pharma plc (RPRX) reported net income of $770.9M for FY2025 (fiscal year ending 2025-12-31), down 10.2% year-over-year. The net profit margin was 32.4% — meaning the company kept $0.32 of every dollar of revenue as profit.

Based on available data, Royalty Pharma plc has been profitable since at least 2015. Net income reached a peak of $2.35B in FY2019. Data available for 11 fiscal years.

Royalty Pharma plc's net profit margin was 32.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Royalty Pharma plc net worth" — the company's market capitalization is a separate figure from RPRX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

RPRX net income · 5 questions

Royalty Pharma plc is profitable. The company reported net income of $770.9M for FY2025, a net profit margin of 32.4%. Net income was down 10.2% year-over-year. Based on available data, Royalty Pharma plc has been profitable since at least 2015.

is RPRX profitabledoes RPRX make a profitRPRX profitabilityRPRX profitable company

▸ Source: FMP /income-statement · GAAP · Royalty Pharma plc · Royalty Pharma plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026